Omnicell

JANUARY 10, 2023

Many often rely on 503B outsourcing pharmacies for their pre-mixed compounded sterile products. At the University of Maryland Medical Center, we reduced our need for 503B vendors by implementing an IV robotics insourcing program for compounded sterile products (CSPs).

Compounding 52

Compounding Omnicell Sterile Compounds Hospitals 52

Omnicell

JANUARY 10, 2023

Terri Albarano, MS, PharmD Director, Autonomous Pharmacy Advisory Board When patients are admitted to the hospital, they are typically focused on receiving the best care. One key area was in sterile compounding of IVs – a big risk area – in which a dosing error could have serious consequences.

Hospitals 52

Hospitals Sterile Compounds Omnicell Patient Care 52

Omnicell

JANUARY 10, 2023

Arpit Mehta Director of Pharmacy, Allegheny General Hospital Like many health systems, we at Allegheny Health Network have been challenged by the cost, compliance, and complexity of compounding sterile products (CSPs). Omnicell's IV compounding robot service offered the holistic solution we needed.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Hospitals 52

Omnicell

JANUARY 10, 2023

Dennis Wright Senior Director, Central Pharmacy Product Marketing, Omnicell As one of the early adopters of the vision of Autonomous Pharmacy , Texas Children's Hospital in Houston saw the opportunity for connected automation, intelligent data, and technology-enabled services to drive radical change in their medication management strategy.

Sterile Compounds 52

Sterile Compounds Omnicell Compounding Hospitals 52

Omnicell

SEPTEMBER 5, 2022

Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. All this means hospitals must prepare the majority of their IVs in-house and, we believe this will continue.

Compounding 52

Compounding Sterile Compounds Compounding Pharmacies Documentation 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

Compounding 52

Compounding Sterile Compounds Omnicell Patient Care 52

Omnicell

MARCH 27, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52

Omnicell

FEBRUARY 14, 2023

Ken Perez Vice President, Healthcare Policy and Government Affairs, Omnicell Nearly every hospital patient receives medications dispensed by pharmacy, and nearly every patient bill includes medications managed by pharmacy. Over the last 12 months, drug spend in the US totaled $576 billion.

Sterile Compounds 52

Sterile Compounds Medication Dispensing Omnicell Hospitals 52